e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

462.90 -0.09 (-0.02%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

69 70 Next >

Vertex Reports First Quarter 2025 Financial Results

May 05, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum? ↗

May 05, 2025

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports Q1 earnings with $4.32 EPS and $2.85B revenue. Stock up 25.48% in past year, charts show bullish trend.

Via Benzinga

Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday? ↗

May 05, 2025

Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services...

Via Benzinga

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

Earnings Outlook For Vertex Pharmaceuticals ↗

May 02, 2025

Via Benzinga

Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

May 05, 2025

Via Benzinga

Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now ↗

May 05, 2025

Now may be a smart time to buy small stakes in these fundamentally robust companies.

Via The Motley Fool

Topics Artificial Intelligence Economy

3 No-Brainer Stocks to Buy in May ↗

May 05, 2025

Via The Motley Fool

5 Growth Stocks to Buy in May and Go Away ↗

May 04, 2025

Via The Motley Fool

Topics Artificial Intelligence Government World Trade

Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow

May 04, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades' ↗

May 01, 2025

Via Benzinga

Topics Stocks

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential ↗

April 30, 2025

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential

Via Chartmill

These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount ↗

April 30, 2025

Via The Motley Fool

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

April 29, 2025

Via Benzinga

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market ↗

April 28, 2025

Via The Motley Fool

Topics Artificial Intelligence Energy

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday ↗

April 22, 2025

Via The Motley Fool

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold ↗

April 22, 2025

Via The Motley Fool

Topics Government

Expert Outlook: Vertex Pharmaceuticals Through The Eyes Of 18 Analysts ↗

April 22, 2025

Via Benzinga

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right ↗

April 22, 2025

Via The Motley Fool

Topics Economy Government World Trade

Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely ↗

April 21, 2025

Vertex Pharmaceuticals is expected to report first quarter earnings on May 5, with investor focus on its two big launches and potential upside surprises.

Via Benzinga

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next ↗

April 18, 2025

Via The Motley Fool

Topics Government World Trade

Peering Into Vertex Pharmaceuticals's Recent Short Interest ↗

April 17, 2025

Via Benzinga

As The Nasdaq 100 Index Crashes, Is It Safe To Buy The Dip? ↗

April 17, 2025

The Nasdaq 100 Index remains under pressure after forming a death cross pattern a few weeks ago. It has retreated to $18,257, down by over 17.8% from its highest point this year.

Via Talk Markets

Topics Stocks / Equities

Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction ↗

April 16, 2025

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...

Via Benzinga

Topics Government

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce ↗

April 15, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades ↗

April 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Government Stocks

CrowdStrike, Robinhood, Palo Alto Networks And A Health Care Stock On CNBC's 'Final Trades' ↗

April 11, 2025

CrowdStrike has expanded its partnership with Google Cloud to enable end-to-end security for AI innovation.

Via Benzinga

Topics Artificial Intelligence

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

April 11, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗

April 11, 2025

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy